From drivers straining to see the road to children who can’t see their textbooks, those in dire need for eyeglasses have taken a backseat to more complex global health priorities, like infectious diseases. 

An unprecedented flow of refugees is testing immunization services across Europe, revealing gaps that put the success of the European Vaccine Action Plan at risk, write Sally Hargreaves and colleagues. 

Big Tobacco, beware: A new global watchdog will soon be on your tail. The search is on for a lead organization for Stopping Tobacco Organizations and Products (STOP) that will aggressively track and monitor tobacco industry practices that undermine public health.

Warmer weather is helping drive a surge in diseases transmitted via mosquitos, ticks and fleas in the US, which have more than tripled in the US in recent years, according to the CDC.

Fresh WHO data shows that 9 in 10 people breathe air laced with high levels of pollutants, and a shocking 7 million people die annually because of it—the vast majority in low and middle-income countries.

The rise of effective medications saw global malaria deaths drop an estimated 60% from 2000-2015—but markets flooded with fake chloroquine and artemisinin are slowing progress against the disease in the hardest-hit African countries, write the University of Canberra’s…

Bill Gates announced Friday a $12 million Grand Challenge to speed up development of a universal flu vaccine, aiming for clinical trials by 2021. The seasonal flu vaccine is a guessing game in matching strain to vaccine that takes 6 months. That timeline leaves us ill-…

Genetics influence a person’s susceptibility to substance abuse disorder but understanding epigenetic factors may be key in fighting opioid dependence.

The HIV/AIDS epidemic risks spinning out of control if current funding trends continue, according to Mark Dybul, a founding architect of PEPFAR.

The WHO says it will decide by 2019 whether to recommend routine antibiotics for infants in poor countries after a large study—known as the Mordor trial—revealed that receiving 2 annual doses of antibiotics reduced infant mortality by as much as 25%.